Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.

Luc CabelFrédérique BergerPaul-Henri CottuDelphine LoiratAurore RampanouEtienne BrainStacy CyrilleHugues BourgeoisNicolas KiavueElise DelucheSylvain LadoireMario CamponeJean-Yves PiergaFrancois-Clement Bidard

Published in: British journal of cancer (2021)

NCT, NCT01349842, https://clinicaltrials.gov/ct2/show/NCT01349842 , registered 9 May 2011.

Keyphrases

metastatic breast cancer
clinical trial
study protocol
open label
phase iii
single cell
phase ii
computed tomography
cell therapy
image quality
dual energy
double blind
locally advanced
contrast enhanced
randomized controlled trial
placebo controlled
mesenchymal stem cells
magnetic resonance
radiation therapy